Neolys Pharma focuses on innovative drug delivery systems and advanced therapeutic solutions, particularly in the field of oncology. The company has developed proprietary technologies that enhance the efficacy and safety of existing treatments, aiming to improve patient outcomes. Their pipeline includes a range of products that leverage these technologies to address unmet medical needs, particularly in cancer care.

The company emphasizes its commitment to scientific research and development, utilizing cutting-edge methodologies to optimize drug formulations and delivery mechanisms. Neolys Pharma's approach integrates a deep understanding of pharmacokinetics and pharmacodynamics, allowing for tailored therapies that can potentially reduce side effects and improve the therapeutic index of drugs. This focus on precision medicine positions Neolys Pharma as a key player in the evolving landscape of pharmaceutical innovation.

Canada

RM-581, a small molecule in early developpement of a new class (the aminosteroids), demonstrated its ability to block the progression or even reduce the size of cancerous tumours that are difficult to treat with conventional chemothérapy.

Le RM-581, une petite molécule en développement préclinique d'une nouvelle classe (les aminostéroïdes), a démontré une capacité à bloquer la progression ou même réduire réduire la taille des tumeurs cancéreuses difficiles à traiter avec la chimiothérapie classique.

2705 boul. Laurier, Québec, QC, Canada,, Quebec City, Quebec G1V 4G2, CA

Neolys Pharma

Company Details